Testing the MyGlucoCare Smartphone Program for Women with Gestational Diabetes Providing Personalized Support During Pregnancy

What this Trial Is About

This research aims to evaluate the MyGlucoCare smartphone program designed to support women with gestational diabetes mellitus GDM. The studys main goal is to test if this program is practical and acceptable for participants, and to observe preliminary effects on diabetes self-management, blood sugar control, and overall well-being. It is a single-arm pilot study involving about 30 pregnant women with GDM. Participants will use the MyGlucoCare app for 8 to 12 weeks during pregnancy. The program includes three components automated personalized education covering GDM management topics, proactive individualized support from a clinician through bi-weekly check-ins and chat responses, and a moderated peer support group to share experiences. Data will be collected before starting, near the end of pregnancy, and postpartum. Women taking part will complete questionnaires, record health data, and some may participate in interviews to share feedback. Researchers will measure engagement with the app, recruitment and retention rates, system usability, self-efficacy, blood glucose levels, physical activity, stress, and pregnancy outcomes. Safety and confidentiality will be maintained throughout, with data collected securely and anonymously.

Feasibility Testing of the "MyGlucoCare" Smartphone App for Women With Gestational Diabetes